Geographic evidence hub
Published infectious-disease research classified with a high-confidence geographic relationship to Australia.
Evidence stream
23 publications
Cochrane Database of Systematic Reviews
Why it matters nowFindings align with routine first-line clinical provision of hearing aids to adults seeking help for hearing difficulties, while signalling ongoing uncertainty around benefits for mental health and cognition.
Communicable Diseases Intelligence
Why it matters nowThe report highlights a high hospital burden from confirmed influenza admissions, alongside moderate severity as indicated by intensive care unit admission proportions, and very low influenza-attributed mortality.
Communicable Diseases Intelligence
Why it matters nowThe report documents an unprecedented two-year suppression of influenza activity in Australia concurrent with COVID-19 PHSMs, providing a descriptive baseline relevant to understanding how non-pharmaceutical measures and pandemic-era conditions can shape seasonal influenza epidemiology.
Wellcome Open Research
Why it matters nowThe compilation frames melioidosis as an escalating yet frequently ignored infectious threat that demands improved monitoring frameworks, uniform testing standards, and interdisciplinary coordination to decrease adverse health outcomes.
Health Education & Behavior
Why it matters nowSkin self-examination represents a secondary prevention approach for early skin cancer detection. Digital visual aids such as smartphone applications may support broader uptake and maintenance of these examination behaviors.
Vaccine
Why it matters nowWaning immunity following acellular pertussis vaccination has been observed in pertussis outbreaks, creating a need for more effective acellular pertussis vaccines. The findings support the potential use of this 2-component vaccine as a pertussis booster in adults.
Vaccine
Why it matters nowImmunization programs may achieve higher enrollment by aligning educational campaigns with accessible, patient-focused service models.
Vaccine
Why it matters nowThe authors highlight the need for vaccine manufacturers and public- and animal-health policymakers to anticipate potentially lower public acceptance of mRNA vaccines and of animal-source foods derived from mRNA-vaccinated livestock, noting that scientific development must be matched by public acceptability for new vaccines to be optimally used.
Eurosurveillance
Why it matters nowThe event demonstrates that sustained immunization programs can be circumvented by specific socioeconomic and environmental risk factors, necessitating targeted monitoring of cutaneous manifestations.
PLOS Neglected Tropical Diseases
Why it matters nowThe findings identify geographic areas where the model estimates greater ecological suitability and conditional potential for human spillover. The authors state that the results may inform targeted surveillance and vector control planning, but the supplied evidence does not establish an ongoing or current transmission signal.
The Lancet Microbe
Why it matters nowThe work supports development of a controlled human infection model that could accelerate novel gonorrhoea prevention and therapeutic strategies, addressing a pathogen of major public health concern due to rising prevalence and antimicrobial resistance. The selection approach prioritizes participant safety and identifies strains relevant for evaluating current and future vaccines.
BMJ open
Why it matters nowDocumented discrepancies in clinical workflows and patient outcomes underscore the necessity for harmonized regional guidelines tailored to specific epidemiological contexts.
Bulletin of the World Health Organization
Why it matters nowThe publication underscores the necessity for enhanced interagency cooperation and expanded preventive healthcare access to manage future zoonotic spillover events effectively.
Influenza and Other Respiratory Viruses
Why it matters nowThe article provides Queensland-specific evidence on influenza activity and vaccine effectiveness during a year when vaccination was publicly funded for all residents. It also reports outcome-specific and age-specific effectiveness estimates, including estimates for hospitalisation.
International Journal of Infectious Diseases
Why it matters nowThe findings support the value of whole genome sequencing for identifying clusters and resistance mutations in low-burden settings, which can inform contact tracing, surveillance, and treatment strategies for drug-resistant TB.
BMC Infectious Diseases
Why it matters nowThe work informs workplace testing policy in Australia by illustrating how surveillance design choices shape detectability of COVID-19 outbreaks in occupational settings.
Vaccine
Why it matters nowThe findings address readiness for COVID-19 vaccine safety monitoring and identify opportunities to enhance pharmacovigilance systems that could contribute to both local and global vaccine safety surveillance. Transparent communication was emphasized as essential for addressing vaccine safety concerns during the pandemic.
Eurosurveillance
Why it matters nowThe findings suggest that movement restrictions within and into Australia may have temporarily eliminated influenza circulation, demonstrating the broader impact of COVID-19 control measures on respiratory disease epidemiology.
PLOS Neglected Tropical Diseases
Why it matters nowThe findings are relevant to hospital treatment policy and guideline maintenance for melioidosis in tropical settings.
Eurosurveillance
Why it matters nowThese unprecedented interseasonal outbreaks followed a mild 2018 influenza season and highlight the need for year-round influenza surveillance even in temperate climates with strong seasonal patterns. The event underscores that interseasonal influenza activity can reach levels comparable to or exceeding typical seasonal peaks.
PLOS Neglected Tropical Diseases
Why it matters nowFindings are relevant for anticipating periods of higher importation risk and considering climatic drivers of overseas chikungunya activity when planning Australian preparedness, given the presence of suitable local vectors.
Emerging Infectious Diseases
Why it matters nowThe report is relevant to transmission investigations for melioidosis because it describes environmental sampling paired with genomic comparison in a suspected inhalational case. It may help contextualize how environmental sources are studied in relation to human infection, without establishing broader frequency or surveillance patterns.
Vaccine
Why it matters nowSurveillance data are essential for vaccine formulation, vaccination policy decisions, and monitoring vaccine impact. The dynamic and regionally variable epidemiology of meningococcal disease necessitates ongoing surveillance to guide public health interventions.
